SUKABUMI, 30 August 2018 - PT Prodia Widyahusada Tbk (ticker symbol: PRDA),...
SUKABUMI, 30 August 2018 - PT Prodia Widyahusada Tbk (ticker symbol: PRDA), the Next Generation Healthcare Provider with the largest medical check-up service network in Indonesia, has inaugurated its 150th outlet in Sukabumi City, West Java. Prodia Sukabumi is located at Jl. Jenderal Sudirman No. 42B, Sukabumi City, West Java. The opening ceremony was attended by the Assistant to the Sukabumi Regional Secretary for the Economy and Development Drs. H. Kostaman, M.M., Managing Director of Prodia Dewi Muliaty, Branch Manager of Prodia Sukabumi Ada Suhada, and other Prodia' s management staff.
Prodia Sukabumi provides blood sampling hematology, immunology, and serology tests glucose level tests HbA1c fat the kidney functions the liver and electrolyte functions and other medical checkups. In the future, Prodia Sukabumi will also offer non-laboratory tests, such as EKG and doctors for physical examination.
Based on the 2014 Health Profile, Sukabumi City has approximately 342,086 people. In 2014, Sukabumi City has 8 hospitals, including regional public hospital, police hospital, military hospital (Indonesia army), private hospital, and maternity hospital 20 auxiliary health centers 10 clinics 184 single-handed general practitioner services, and 68 specialist services. Based on the Strategic Plan of Sukabumi City Health Office in 2015-2018, the communicable disease rate in Sukabumi City is relatively high for the last five years. The top three communicable diseases in 2014 included dengue fever with 705 cases, URTI-Pneumonia with 2,685 cases, and diarrhea with 13,334 cases.
Managing Director of Prodia Dewi Muliaty said that the opening of the first Prodia branch in Sukabumi was hand in hand with Prodia' s commitment to provide quality medical checkup services for all people. "We' re glad and proud to open the first branch of Prodia in Sukabumi. We hope that Prodia Sukabumi can help the community to build a healthier city. We're ready to provide Sukabumi community with excellent services," Dewi said in the Grand Opening of Prodia Sukabumi (30/8).
Branch Manager of Prodia Sukabumi Ada Suhada added that apart from providing medical checkup services for the community, Prodia Sukabumi also aspires to partner with the local government, general practitioners, hospitals, clinics, and companies in order to provide comprehensive medical checkup services. "We hope that we can partner local government, general practitioners, and hospitals to provide the best medical checkup services," said Ada.
Currently, Prodia has e-Prodia facility which is an online registration and payment system for Prodia' s customers. This facility accommodates the customers' needs to register, choose the desired type of checkups, determine the check-up location, and make the payment in their favor. The online Registration and Payment System are accessible through PC, tablet, iPad, and cellphone.
In early 2018, Prodia has launched an Anatomic Pathology Laboratory integrated with molecular pathology to support precision medicine service at Prodia National Reference Laboratory, Jl. Kramat Raya No. 150, Jakarta. Anatomic Pathology Laboratory is a clinical laboratory specialized in providing tests on human tissue specimen (histopathology), body fluid sample (cytopathology), and protein expressions in the tissue or in human cells (immunohistochemistry). These tests are the gold standard for certain disease diagnosis. In addition, Prodia also provides a cytogenetics service for the genetics test and chromosome analysis. The cytogenetics service completes Prodia' s medical check-up services, especially in the genetics test.
Prodia has also launched several new tests such as gene mutation test EGFR ctCDNA and EGFR Mutation T790M, an ultrasensitive test for the treatment of lung cancer, ProHealthy Gut for intestinal health checkup, ProSafe for non-invasive prenatal testing (NIPT), which is a prime diagnostic test to detect down syndrome during pregnancy, and collaborated on the Telomere Analysis to provide information on human biological age. Prodia is the pioneer of clinical laboratory in Indonesia that serves the latest medical tests.
*****
About PT Prodia Widyahusada Tbk
Prodia Clinical Laboratory was initially established in Solo on 7 May 1973 by a group of idealist pharmacists. From the very first, Dr. Andi Widjaja, MBA along with the other founders have been committed to present the best test results with wholehearted services.
As the market leader, since 2012 Prodia has been the only laboratory and clinic in Indonesia accredited by the College of American Pathologists (CAP). It implies that Prodia' s test results are equal in quality to those obtained from other international laboratories.
On 7 December 2016, the Indonesia Stock Exchange officially listed the initial public offering of Prodia as the 15th issuer in 2016, with the ticker symbol 'PRDA' . In that corporate action, Prodia offered 187.5 million shares. Accordingly, the fund raised from the Company' s initial public offering (IPO) was Rp1.22 trillion.
Currently, Prodia has had the service network that incorporates 288 outlets, consisting of 141 clinical laboratories across 33 provinces and 121 cities in Indonesia, Prodia Health Care (PHC) - a personalized medicine-based wellness clinic - and specialty clinics, including Prodia Children' s Health Centre (PCHC), Prodia Women' s Health Centre (PWHC), and Prodia Senior Health Centre (PSHC).
For further information, please contact:
|
Marina Eka Amalia Legal Head & Corporate Secretary PT Prodia Widyahusada Tbk Ph. +62-21-3144182 ext 3816 Email corporate.secretary@prodia.co.id |
Magdalena Vandry Investor Relation Head PT Prodia Widyahusada Tbk Ph. +62-21-3144182 ext 3775 Email investor.relation@prodia.co.id |